RSCI (Redwood Scientific Technologies) EV-to-FCF: -1.94 (As of Jul. 10, 2026)


What is Redwood Scientific Technologies EV-to-FCF?

Redwood Scientific Technologies RSCI EV-to-FCF is -1.94 as of Jul. 10, 2026.

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Redwood Scientific Technologies's Enterprise Value is $2.27 Mil. Redwood Scientific Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.17 Mil. Therefore, Redwood Scientific Technologies's EV-to-FCF for today is -1.94.

The historical rank and industry rank for Redwood Scientific Technologies's EV-to-FCF or its related term are showing as below:

RSCI' s EV-to-FCF Range Over the Past 10 Years
Min: -1.94   Med: 0   Max: 0
Current: -1.94
RSCI's EV-to-FCF is not ranked
in the Drug Manufacturers industry.
Industry Median: 20.765 vs RSCI: -1.94

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-10), Redwood Scientific Technologies's stock price is $0.0111. Redwood Scientific Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.020. Therefore, Redwood Scientific Technologies's PE Ratio (TTM) for today is At Loss.

Redwood Scientific Technologies  (OTCPK:RSCI) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Redwood Scientific Technologies's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.0111/-0.020
=At Loss

Redwood Scientific Technologies's share price for today is $0.0111.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redwood Scientific Technologies's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.020.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Redwood Scientific Technologies EV-to-FCF Related Terms

Redwood Scientific Technologies EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Redwood Scientific Technologies's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Redwood Scientific Technologies EV-to-FCF Chart

Redwood Scientific Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-FCF
-181.20 0.00 0.00 -19.17

Redwood Scientific Technologies Semi-Annual Data
Dec20 Dec21 Dec22 Dec23
EV-to-FCF 0.00 0.00 0.00 -19.17

RSCI vs RAPH, FLGC, TXMD: EV-to-FCF Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Redwood Scientific Technologies's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Redwood Scientific Technologies EV-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Redwood Scientific Technologies's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Redwood Scientific Technologies's EV-to-FCF falls into.


Redwood Scientific Technologies EV-to-FCF Calculation

Redwood Scientific Technologies's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2.266/-1.169
=-1.94

Redwood Scientific Technologies's current Enterprise Value is $2.27 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Redwood Scientific Technologies's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.17 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-FCF →
What does a EV-to-FCF of -1.94 mean?
Redwood Scientific Technologies (RSCI) has a EV-to-FCF of -1.94 as of Jul. 10, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Redwood Scientific Technologies and its competitors.
Is Redwood Scientific Technologies' EV-to-FCF too high?
Redwood Scientific Technologies' current EV-to-FCF is -1.94.
How does Redwood Scientific Technologies' EV-to-FCF compare to RAPH and FLGC?
Redwood Scientific Technologies' EV-to-FCF of -1.94 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-FCF is 20.77. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.77, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Redwood Scientific Technologies and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Redwood Scientific Technologies's current EV-to-FCF is -1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redwood Scientific Technologies stock overvalued right now?
Redwood Scientific Technologies (RSCI) has a current EV-to-FCF of -1.94. The current EV-to-FCF is -1.94. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Redwood Scientific Technologies (RSCI), the current EV-to-FCF is -1.94 as of Jul. 10, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Redwood Scientific Technologies Business Description

Address 418 Broadway, STE 4872, Albany, NY, USA, 12207
Redwood Scientific Technologies Inc is a pharmaceutical delivery company that develops, operates, and markets over-the-counter products in a sublingual oral thin film strip. RSCI has begun clinical trials on two new products to market for stopping the addiction to nicotine.